Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pomper

Showing results (161-170 of 525) with videos related to

Pageof 53
Sort By:
Bioconjugate Chemistry|June 9, 2016
[(18)F]Fluoroethyl Triazole Substituted PSMA Inhibitor Exhibiting Rapid Normal Organ ClearanceYing Chen, Ala Lisok, Samit Chatterjee, et al.
Neuroimage|October 27, 2009
Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIVDima A Hammoud, Christopher J Endres, Edward Hammond, et al.
Seminars in Nuclear Medicine|May 26, 2023
Role of Functional SPECT and PET in Renal EmergenciesTakahiro Higuchi, Philipp E Hartrampf, Andreas K Buck, et al.
Molecular Imaging and Biology|August 3, 2016
MR-Guided Delivery of Hydrophilic Molecular Imaging Agents Across the Blood-Brain Barrier Through Focused UltrasoundRaag D Airan, Catherine A Foss, Nicholas P K Ellens, et al.
Nuclear Medicine and Biology|May 4, 2024
A third generation PSMA-targeted agent [<sup>211</sup>At]YF2: Synthesis and in vivo evaluationYutian Feng, Rebecca L Meshaw, Sean W Finch, et al.
Pharmaceutical Research|April 4, 2007
FDG-PET for pharmacodynamic assessment of the fatty acid synthase inhibitor C75 in an experimental model of lung cancerJae Sung Lee, Hajime Orita, Kathleen Gabrielson, et al.
Journal of Clinical Medicine|July 24, 2019
Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers-Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CTRudolf A Werner, James T Thackeray, Martin G Pomper, et al.
Molecular Pharmaceutics|March 27, 2019
MRI Assessment of Prostate-Specific Membrane Antigen (PSMA) Targeting by a PSMA-Targeted Magnetic Nanoparticle: Potential for Image-Guided TherapyEthel J Ngen, Babak Benham Azad, Srikanth Boinapally, et al.
Nuclear Medicine and Biology|February 18, 2015
[(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChRYongjun Gao, Ronnie C Mease, Thao T Olson, et al.
Journal of Medicinal Chemistry|June 27, 2013
Effect of chelators on the pharmacokinetics of (99m)Tc-labeled imaging agents for the prostate-specific membrane antigen (PSMA)Sangeeta Ray Banerjee, Mrudula Pullambhatla, Catherine A Foss, et al.
Pageof 53

Showing results (161-170 of 525) with videos related to

Sort By:
Pageof 53
Bioconjugate Chemistry|June 9, 2016
[(18)F]Fluoroethyl Triazole Substituted PSMA Inhibitor Exhibiting Rapid Normal Organ ClearanceYing Chen, Ala Lisok, Samit Chatterjee, et al.
Neuroimage|October 27, 2009
Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIVDima A Hammoud, Christopher J Endres, Edward Hammond, et al.
Seminars in Nuclear Medicine|May 26, 2023
Role of Functional SPECT and PET in Renal EmergenciesTakahiro Higuchi, Philipp E Hartrampf, Andreas K Buck, et al.
Molecular Imaging and Biology|August 3, 2016
MR-Guided Delivery of Hydrophilic Molecular Imaging Agents Across the Blood-Brain Barrier Through Focused UltrasoundRaag D Airan, Catherine A Foss, Nicholas P K Ellens, et al.
Nuclear Medicine and Biology|May 4, 2024
A third generation PSMA-targeted agent [<sup>211</sup>At]YF2: Synthesis and in vivo evaluationYutian Feng, Rebecca L Meshaw, Sean W Finch, et al.
Pharmaceutical Research|April 4, 2007
FDG-PET for pharmacodynamic assessment of the fatty acid synthase inhibitor C75 in an experimental model of lung cancerJae Sung Lee, Hajime Orita, Kathleen Gabrielson, et al.
Journal of Clinical Medicine|July 24, 2019
Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers-Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CTRudolf A Werner, James T Thackeray, Martin G Pomper, et al.
Molecular Pharmaceutics|March 27, 2019
MRI Assessment of Prostate-Specific Membrane Antigen (PSMA) Targeting by a PSMA-Targeted Magnetic Nanoparticle: Potential for Image-Guided TherapyEthel J Ngen, Babak Benham Azad, Srikanth Boinapally, et al.
Nuclear Medicine and Biology|February 18, 2015
[(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChRYongjun Gao, Ronnie C Mease, Thao T Olson, et al.
Journal of Medicinal Chemistry|June 27, 2013
Effect of chelators on the pharmacokinetics of (99m)Tc-labeled imaging agents for the prostate-specific membrane antigen (PSMA)Sangeeta Ray Banerjee, Mrudula Pullambhatla, Catherine A Foss, et al.
Pageof 53